다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Gut and liver, v.10 no.2, 2016년, pp.295 - 302
Ahn, Jem Ma (Division of Gastroenterology and Hepatology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea) , Paik, Yong-Han (Division of Gastroenterology and Hepatology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea) , Min, Sin Yeong (Division of Gastroenterology and Hepatology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea) , Cho, Ju Yeon (Division of Gastroenterology and Hepatology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea) , Sohn, Won (Division of Gastroenterology and Hepatology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea) , Sinn, Dong Hyun (Division of Gastroenterology and Hepatology, Department of Medicine, Samsung Medical Center, Sungkyunkwan Univ) , Gwak, Geum-Youn , Choi, Moon Seok , Lee, Joon Hyeok , Koh, Kwang Cheol , Paik, Seung Woon , Yoo, Byung Chul
AI-Helper
Background/AimsThe aim of this study was to evaluate the relationship between controlled attenuation parameter (CAP) and hepatic steatosis, as assessed by ultrasound (US) in patients with alcoholic liver disease (ALD) or non-alcoholic fatty liver disease (NAFLD).MethodsPatients with either ALD or NA...
1 Levene AP Goldin RD The epidemiology, pathogenesis and histopathology of fatty liver disease Histopathology 2012 61 141 152 10.1111/j.1365-2559.2011.04145.x 22372457
2 Lazo M Clark JM The epidemiology of nonalcoholic fatty liver disease: a global perspective Semin Liver Dis 2008 28 339 350 10.1055/s-0028-1091978 18956290
3 Bellentani S Saccoccio G Masutti F Prevalence of and risk factors for hepatic steatosis in Northern Italy Ann Intern Med 2000 132 112 117 10.7326/0003-4819-132-2-200001180-00004 10644271
4 Cerović I Mladenović D Ješić R Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease Eur J Gastroenterol Hepatol 2013 25 899 904 10.1097/MEG.0b013e32835f0786 23426271
5 Myers RP Pollett A Kirsch R Controlled attenuation parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography Liver Int 2012 32 902 910 10.1111/j.1478-3231.2012.02781.x 22435761
6 Yeh MM Brunt EM Pathological features of fatty liver disease Gastroenterology 2014 147 754 764 10.1053/j.gastro.2014.07.056 25109884
7 Tuyama AC Chang CY Non-alcoholic fatty liver disease J Diabetes 2012 4 266 280 10.1111/j.1753-0407.2012.00204.x 22564417
8 Starley BQ Calcagno CJ Harrison SA Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection Hepatology 2010 51 1820 1832 10.1002/hep.23594 20432259
9 Sung KC Wild SH Kwag HJ Byrne CD Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people Diabetes Care 2012 35 2359 2364 10.2337/dc12-0515 3476919 --> 22829522
10 Rockey DC Caldwell SH Goodman ZD Nelson RC Smith AD American Association for the Study of Liver Diseases Liver biopsy Hepatology 2009 49 1017 1044 10.1002/hep.22742 19243014
11 Grant A Neuberger J Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology Gut 1999 45 Suppl 4 IV1 IV11 10.1136/gut.45.2008.iv1 1766696 --> 10485854
12 Bohte AE van Werven JR Bipat S Stoker J The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis Eur Radiol 2011 21 87 97 10.1007/s00330-010-1905-5 2995875 --> 20680289
13 Schwenzer NF Springer F Schraml C Stefan N Machann J Schick F Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance J Hepatol 2009 51 433 445 10.1016/j.jhep.2009.05.023 19604596
14 Hamaguchi M Kojima T Itoh Y The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation Am J Gastroenterol 2007 102 2708 2715 10.1111/j.1572-0241.2007.01526.x 17894848
15 Dasarathy S Dasarathy J Khiyami A Joseph R Lopez R Mc-Cullough AJ Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study J Hepatol 2009 51 1061 1067 10.1016/j.jhep.2009.09.001 19846234
16 de Lédinghen V Vergniol J Capdepont M Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations J Hepatol 2014 60 1026 1031 10.1016/j.jhep.2013.12.018 24378529
17 Sasso M Beaugrand M de Ledinghen V Controlled attenuation parameter (CAP): a novel VCTE TM guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis. Preliminary study and validation in a cohort of patients with chronic liver disease from various causes Ultrasound Med Biol 2010 36 1825 1835 10.1016/j.ultrasmedbio.2010.07.005 20870345
18 Sasso M Miette V Sandrin L Beaugrand M The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan Clin Res Hepatol Gastroenterol 2012 36 13 20 10.1016/j.clinre.2011.08.001 21920839
19 Castera L Forns X Alberti A Non-invasive evaluation of liver fibrosis using transient elastography J Hepatol 2008 48 835 847 10.1016/j.jhep.2008.02.008 18334275
20 de Lédinghen V Vergniol J Foucher J Merrouche W le Bail B Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography Liver Int 2012 32 911 918 10.1111/j.1478-3231.2012.02820.x 22672642
21 Chon YE Jung KS Kim SU Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population Liver Int 2014 34 102 109 10.1111/liv.12282 24028214
22 Kumar M Rastogi A Singh T Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance? J Gastroenterol Hepatol 2013 28 1194 1201 10.1111/jgh.12134 23425053
23 Carvalhana S Leitão J Alves AC Bourbon M Cortez-Pinto H How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound Liver Int 2014 34 e111 e117 10.1111/liv.12305 24034415
24 Scaglioni F Ciccia S Marino M Bedogni G Bellentani S ASH and NASH Dig Dis 2011 29 202 210 10.1159/000323886 21734385
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.